Meloxicam is a nonsteroidal anti-inflammatory (NSAID) class drug that is indicated for treating pain and inflammation in conditions such as rheumatoid arthritis and osteoarthritis. Suppliers market it as7.5mg and 15mg tablets, although it is also available in oral solution form. Meloxicam was developed by the manufacturer and supplier Boehringer Ingelheim, and first approved for medical use in 2000. Currently, it is marketed in over 100 countries, with over 20 million prescriptions made out yearly in the U.S. alone. And, following Boehringer Ingelheim’s patent expiry in 2006, numerous other manufacturing companies and suppliers, such as Apotex, TerSera Therapeutics, and Teva, have introduced their generic as well as trade name formulations of meloxicam. The primary alternatives to meloxicam are other NSAID class drugs, such as ibuprofen, naproxen, aspirin, diclofenac, or celecoxib. Although meloxicam has a broadly similar safety profile to other NSAIDs, it is associated with less gastrointestinal side-effects than diclofenac and naproxen. Meloxicam is prescribed to alleviate the symptoms of osteoarthritis and rheumatoid arthritis. Additionally, it is recommended for patients 2 years of age and older with the pauciarticular and polyarticular forms of juvenile rheumatoid arthritis (JRA). Treatment of dental or post-surgical pain is one example of an off-label application. Meloxicam has also been investigated for the treatment of acute pain in addition to the aforementioned uses.

It inhibits the enzymes prostaglandin synthetase (cylooxygenase 1 and 2). Inhibiting prostaglandin production has analgesic and inflammatory effects because prostaglandins stimulate neuronal pain receptors. Meloxicam mostly inhibits COX-2, however it also has some efficacy against COX-1, irritating the stomach. Meloxicam is expected to induce less stomach discomfort than other NSAIDS since it preferentially inhibits COX-2. Despite this, there is still a chance of stomach ulcers, bleeding, and inflammation. In one study, individuals on meloxicam experienced digestive problems at a rate of 13% compared to 19% of those taking diclofenac. The patients receiving meloxicam were observed to have less severe GI issues.

The retail prices for 20 (15mg) tablets of meloxicam fall into an approximate range of 2.00 EUR to 8.00 EUR, whereas 5 injectable solutions of meloxicam at a concentration of 15mg/1.5ml can cost anywhere from 4.00 EUR to 8.00 EUR. The retail prices of Meloxicam medications vary depending on the other active ingredients in the formulation, whether it is a generic or trade name formulation, as well as supplier and manufacturer pricing. Also the costs of Meloxicam vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. Meloxicam suppliers, on the whole, are in favor of patient aid initiatives. Meloxicam is available for sale from various Meloxicam vendors at multiple costs.

Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Meloxicam manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. PipelinePharma is the most reliable source for this medication. Finding an honest partner in our business is one of the significant challenges. To overcome this challenge and make one's life easier when looking for a direct manufacturer and supplier of Meloxicam, one can go to the Pipelinepharma website, which assists buyers in locating dependable manufacturers and suppliers of Meloxicam.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Meloxicam offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Meloxicam suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Meloxicam. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Meloxicam is already registered. Manufacturers also have special delivery terms.

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Meloxicam suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.